Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
1.260
+0.040 (3.28%)
At close: Apr 1, 2025, 4:00 PM
1.280
+0.020 (1.60%)
After-hours: Apr 1, 2025, 4:25 PM EDT

Galectin Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Galectin Therapeutics.

Analyst Consensus: Hold
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

According to 1 stock analyst, the rating for Galectin Therapeutics is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 110000
Buy 000000
Hold 001111
Sell 000000
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Dec 27, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$11
Strong Buy Reiterates $11 +773.02% Nov 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$11
Strong Buy Reiterates $11 +773.02% Aug 16, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$11
Strong Buy Reiterates $11 +773.02% Apr 9, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$11
Strong Buy Reiterates $11 +773.02% Apr 1, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.94
from -0.76
EPS Next Year
-1.16
from -0.94
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028
Revenue
37.05M183.28M392.95M583.66M
Revenue Growth
-394.74%114.40%48.53%----
EPS
-0.41-0.52-0.65-0.74-0.76-0.94-1.16-
EPS Growth
--------
Forward PE
--------
No. Analysts -----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 2025202620272028
High 38.1M 188.7M 404.5M
Avg 37.0M 183.3M 393.0M
Low 35.6M 176.1M 377.5M

Revenue Growth

Revenue Growth 2025202620272028
High -
409.3%
120.7%
Avg -
394.7%
114.4%
Low -
375.4%
106.0%

EPS Forecast

EPS 20252026
High -0.97 -1.20
Avg -0.94 -1.16
Low -0.90 -1.12

EPS Growth

EPS Growth 20252026
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.